Meningococcal B vaccine funding to expand for children under five
In this story Pharmac
Pharmac will fund the Bexsero vaccine for all children under five from 1 September. This decision expands eligibility beyond the current immunisation schedule for infants. The move is expected to provide free protection against meningococcal B for thousands more children.

